Combining hydroxychloroquine and dexamethasone for ITP with positive ANA
Treatments studied
Part of Blood & lymphatic, Immune system & allergy clinical trials.
This trial tests if adding hydroxychloroquine (HCQ) to the steroid dexamethasone (DEX) works better than dexamethasone alone for adults with immune thrombocytopenia (ITP) who have a positive antinuclear antibody (ANA) blood test. The goal is to see if this combination can safely raise platelet counts and reduce bleeding risk.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 15 and 75 years old.
- You have immune thrombocytopenia (ITP) with low platelet counts: either under 30,000 or under 50,000 with bleeding symptoms.
- Your blood test shows a positive antinuclear antibody (ANA).
- Other specific autoantibodies (like dsDNA, SSA, SSB, RNP, β2-GP, ACA, ANCA) are negative.
- Your blood clotting times (PT and aPTT) are nearly normal, and you have no history of clotting problems except from ITP.
- You are not pregnant, breastfeeding, or planning to become pregnant, and you agree to use effective birth control during the trial and for 28 days after.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a combination of hydroxychloroquine (HCQ) and prednisone (a steroid) is safe and effective for treating immune thrombocytopenia (ITP) in people who have a positive ANA blood test. It may be an option for those with low platelets and bleeding risk.
This trial tests if combining two medicines (HCQ and a TPO-RA) can help people with a type of low platelet count called ITP who also have a positive ANA blood test. The goal is to see if this combination works better than standard treatments.
This trial tests a new combination of two medicines—romiplostim N01 (a shot to raise platelets) and rituximab (an infusion that calms the immune system)—for people with primary immune thrombocytopenia (ITP) who have not had enough improvement from oral TPO-RA pills like hetrombopag or eltrombopag. It aims to see if this combination works better and is safe.
This trial tests how many cycles of high-dose dexamethasone (a steroid) work best for adults newly diagnosed with ITP, a condition that causes low platelets and bruising or bleeding. The goal is to find the right dose schedule to safely raise platelet counts.
This trial tests a combination of upadacitinib (a pill that calms the immune system) and high-dose dexamethasone (a steroid) as the first treatment for adults with newly diagnosed immune thrombocytopenia (ITP). It aims to see if this mix can safely raise platelet counts better than steroids alone.
This study tests a combination of multiple drugs given in sequence to adults with newly diagnosed immune thrombocytopenia (ITP), a condition of low platelets. The goal is to see if this approach improves platelet counts and is safe.
Hear when a new Immune Thrombocytopenia With Positive ANA Antibodies trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.